Handelsavisen
prelaunch
Companies Healthcare 3373.TWO
33
3373.TWO TPEx Medical Equipment, Supplies & Distribution

3373.Two

$16,80
Open in Charts → Attach watcher ⌖
USD
Set alert
Last 30 days
1D5D1M3M6MYTD1Y5YMax
Live price chart loads from the market-data widget.
Mcap
P/E
EV / Rev
Div yield
0,00 %
Op margin
-18,2 %
ROE
-7,6 %
Net margin
-15,6 %
Debt / equity
0,00
Beta
52w range
Volume
Day range
Prev close
Open
Next earnings
Ex-dividend
TR 1Y
About

3373.TWO operates in the medical equipment, supplies, and distribution industry, providing healthcare services and equipment to customers in the healthcare sector.

Business. 3373.TWO operates in the medical equipment, supplies, and distribution industry, providing healthcare services and equipment to customers in the healthcare sector.

Classification92 %
SectorHealthcare
Business sectorHealthcare Services & Equipment
IndustryMedical Equipment, Supplies & Distribution
ActivityHealthcare Services & Equipment
Generated · model-assisted
Sell-side consensus
consensus pending
— buy— hold— sell
Avg 12m price target
Upcoming events
— missing data
See all catalysts →

At a glance

Score
not yet scored
Valuation
valuation pending
Analysts
not yet wired
Ownership
not yet wired
Profitability
-7,6 %
return on equity
Quality
not yet scored

What drives this business

The watch-list the newsroom runs for this company — derived from its sector path, sharpened layer by layer. Not investment advice.

— missing data

News & coverage

0
  • No recent newsroom coverage mentioning 3373.
  • Sector rotation

    Sector1D1Mvs mkt
    Materials+2,3 %+6,6 %+1,7 %
    Communication Services+2,2 %−5,5 %+1,6 %
    Energy+0,6 %+3,3 %+0,0 %
    Health Care · THIS SECTOR+0,6 %−0,8 %+0,0 %
    Information Technology+0,6 %+6,7 %+0,0 %
    Consumer Discretionary+0,4 %+7,6 %−0,2 %
    Financials−0,3 %−2,8 %−0,9 %
    Consumer Staples−0,4 %+2,5 %−1,0 %
    Real Estate−0,7 %+10,9 %−1,3 %
    Industrials−1,9 %−3,1 %−2,5 %
    Utilities−1,9 %+28,2 %−2,5 %

    Developing storylines

    No tracked sagas currently linked to 3373.TWO. Browse all sagas →

    Analysis

    AI analysis
    Generated · analysis pipeline · tier hybrid · as of 2026-08-04 ↑ At a glance

    Opportunity

    — missing data

    Upcoming catalysts

    Scheduled public events. Informational only — not investment advice.

    • Macro
    • Rate decisionBank of England rate decision (press conf.)2026-08-06 · GB
    • Rate decisionReserve Bank of Australia rate decision (press conf.)2026-08-12 · AU
    • Rate decisionNorges Bank rate decision (press conf.)2026-08-20 · NO
    • Rate decisionSveriges Riksbank rate decision (press conf.)2026-09-03 · SE
    • Rate decisionBank of Canada rate decision (press conf.)2026-09-09 · CA
    • Rate decisionEuropean Central Bank rate decision (press conf.)2026-09-10 · EU
    • Macro & political
    • ElectionSE Swedish Election2026-09-14 · SE
    • ElectionUS U.S. Midterms2026-11-03 · US
    • ElectionFR French Legislative2027-06-01 · FR

    Pre-earnings brief

    — missing data

    Signals & dispatch

    peak dispatch · —

    Composite-score breakdown

    Synthesis

    Business

    3373.TWO operates in the medical equipment, supplies, and distribution industry, providing healthcare services and equipment to customers in the healthcare sector.

    Classification92 %
    SectorHealthcare
    Business sectorHealthcare Services & Equipment
    IndustryMedical Equipment, Supplies & Distribution
    ActivityHealthcare Services & Equipment
    AI synthesis
    GENERATED

    3373.TWO has a strong liquidity position, with a current ratio of 9.69, indicating that the company holds significantly more current assets than current liabilities. The company maintains no long-term debt and holds TWD 134.75 million in cash and equivalents, which supports its liquidity profile. However, the company reported negative free cash flow of TWD -45.71 million, driven by capital expenditures of TWD -8.04 million and operating cash flow of TWD 2.79 million.

    Profitability metrics for 3373.TWO are negative, with a return on equity of -7.61% and a return on assets of -7.02%. These figures indicate that the company is not generating returns for its shareholders or effectively utilizing its assets. Gross profit of TWD 60.01 million is insufficient to cover operating expenses, as evidenced by an operating loss of TWD -70.36 million.

    The company's revenue is concentrated in a single business segment, as disclosed in its financial statements, with no geographic breakdown provided in the available data. This lack of diversification may expose the company to higher operational and market risks if the segment faces challenges.

    Growth trajectory for 3373.TWO is currently negative, with a net loss of TWD -60.45 million and an operating loss of TWD -70.36 million. The company has not provided forward-looking guidance, and historical revenue trends do not indicate a clear upward trajectory. The negative operating cash flow and free cash flow further suggest that the company is not generating sufficient internal cash to support growth initiatives.

    Risk factors for 3373.TWO include the absence of long-term debt, which reduces financial leverage risk, but the company's negative operating and net income indicate operational risk. The risk assessment indicates low liquidity and dilution risk, with no immediate filing-based flags detected. However, the company's negative returns and cash flow metrics suggest that it may need to raise additional capital in the future, which could lead to dilution for existing shareholders.

    Recent events for 3373.TWO include the latest financial filing, which shows a significant operating and net loss. No recent earnings call transcripts or other material events are available in the provided data.

    Key takeaways
    • 3373.TWO has a strong liquidity position with a current ratio of 9.69 and no long-term debt.
    • The company is not profitable, with a return on equity of -7.61% and a return on assets of -7.02%.
    • Revenue is concentrated in a single business segment, with no geographic diversification disclosed.
    • The company reported a net loss of TWD -60.45 million and an operating loss of TWD -70.36 million.
    • Risk assessment indicates low liquidity and dilution risk, but the company may need to raise capital in the future.

    Bull / Bear case

    analysis pipeline
    — missing data

    In focus — financials by report

    Valuation

    Market price
    $16,80
    Market cap
    Enterprise value
    P/E
    Non-GAAP P/E
    EV / Revenue
    EV / Op income
    EV / OCF
    P / B
    P / Tangible book
    Tangible book
    $793.8M
    Net cash
    $134.7M
    Current ratio
    9.7
    Debt / equity
    0.0
    ROA
    -7.0%
    ROE
    -7.6%
    Cash conversion
    -5.0%
    CapEx / revenue
    -2.1%
    SBC / revenue
    Dilution ratio
    0.0%

    Revenue by segment

    Market share

    — missing data

    Business relationships

    — missing data

    Supply chain

    — missing data

    Peer comparison

    — missing data

    Market position

    Stress test

    — missing data

    Predictor forecast

    Options

    — missing data

    Short squeeze

    — missing data

    Earnings-call key lines

    — missing data

    Estimate revisions

    consensus EPS · 26-week trend
    — missing data

    Sell-side observations

    — missing data

    Themes

    — missing data

    ESG

    — missing data

    Risk factors

    Dilution riskLow
    Liquidity riskLow
    Filing-based flags
    • No immediate filing-based liquidity or dilution flags were detected.

    Benchmarks vs cohort

    Op Margin-18,1 %Below median
    Net Margin-15,6 %Below median
    ROE-7,6 %Below median
    Capex / Rev-2,1 %Above P75
    D/E0,00Above P75
    Cash Conv-0,05Bottom quartile

    Corporate actions / M&A

    — missing data

    FX exposure

    — missing data

    Comparable transactions

    — missing data

    Derivatives & instruments

    — missing data

    Actions

    Ask Handelsavisen

    — missing data
    Data sources
    • Market data
    • Market data cache
    • Issuer disclosures
    • Public news
    • Earnings transcripts
    • Consensus estimates
    • ESG data
    How metrics are computed
    • Dilution Ratio
      (shares_outstanding_diluted - shares_outstanding_basic) / shares_outstanding_basic
    • Net Cash
      cash_and_equivalents + short_term_investments - short_term_debt - long_term_debt
    • Capex To Revenue
      capital_expenditure / revenue
    • Return On Equity
      net_income / total_equity
    • Debt To Equity
      (short_term_debt + long_term_debt) / total_equity
    • Cash Conversion Ratio
      operating_cash_flow / net_income
    Source documents
    • 3373.TWO Market data — financials · 2026-05-26

    Ownership & reference

    Insider activity

    — missing data

    Short positioning

    — missing data

    Geographic breakdown

    — missing data
    Listings · one canonical issuer all listings resolve to the canonical
    3373.TWOCanonical
    TPEx · USD

    Intel & risk

    peak dispatch · —
    OSINT findings
    Dilution riskLow
    Liquidity riskLow
    No immediate filing-based liquidity or dilution flags were detected.

    Evidence & claims

    From filings & derived data
    — missing data

    The Thread

    Everything we know, in order
    2026-06-20 12:34 UTCANALYSTAnalyst coverage initiated
    The entity's full life in the product — typed, chronological, joined across Newspaper, Platform and Data. Our memory, made visible.
    Sources filings · IR · transcripts · market data · tier hybrid · as of 2026-08-04 Market data · Issuer disclosures · Public news · Earnings transcripts · Consensus estimates · ESG data Premium coverage